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ABSTRACT: The objective of this study was 
to evaluate the effects of eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA) supple-
mentation to ewes during late gestation on fin-
ishing lamb liver and adipose tissue fatty acid 
(FA) profile and gene expression. Lambs born 
from ewes supplemented with Ca salts of EPA + 
DHA, or palm FA distillate (PFAD) high in palm-
itic and oleic acid at 0.39% DM during the last 50 
d of gestation were used. Lambs were weaned at 
61 d of age and adapted to a high concentrate diet 
for 1.5 mo. After adaptation, 74 lambs (28 pens) 
were blocked by sex and BW and used in a 2 × 
2 factorial arrangement of treatments using the 
factors of dam supplementation (DS) and lamb 
supplementation (LS) of Ca salts of EPA + DHA 
or PFAD at 1.48% DM. Lambs were slaugh-
tered after 42 d and liver and adipose tissue col-
lected for FA and gene expression analysis. Liver 
concentrations of EPA and DHA were greater 
(P  <  0.01) with LS of EPA + DHA vs. PFAD 
during the finishing period. In adipose tissue, a 
lamb × dam interaction was observed for EPA 
(P  =  0.02) and DHA (P  =  0.04); LS of EPA + 
DHA increased EPA and DHA, but the increase 
was greatest in lambs born from ewes supple-
mented with PFAD. No lamb × dam treatment 
interactions were observed for gene expression 
in liver tissue (P > 0.10). Hepatic mRNA abun-
dance of hormone-sensitive lipase (HSL; P = 0.01) 
was greater in lambs born from EPA + DHA ewes 
vs. lambs from PFAD ewes. mRNA expression 
of stearoyl-CoA desaturase (P < 0.01), fatty acid 
synthase (P = 0.01), Δ5-desaturase (P < 0.01), and 
Δ6-desaturase (P < 0.01) were decreased in liver of 
EPA + DHA lambs. A significant lamb × dam diet 
interaction was observed for elongation of very 
long chain fatty acid 2 in adipose tissue (P = 0.01); 
lambs supplemented with the same FA as their 
dams had lower expression. Expression of HSL 
tended (P = 0.08) to be decreased in adipose of 
EPA + DHA lambs born from EPA + DHA ewes. 
The changes in mRNA expression suggest that 
lipogenesis decreased, and lipolysis increased in 
lamb liver with EPA + DHA vs. PFAD supple-
mentation during the finishing period. In adipose 
tissue, changes suggest that lipogenesis decreased 
in lambs born from EPA + DHA supplemented 
dams and supplemented with EPA + DHA during 
the finishing period. In addition, these results 
suggest an interaction between supplementation 
of FA to dams during late gestation on lamb re-
sponse of adipose tissue, but not liver, to FA sup-
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INTRODUCTION
Feeding fatty acids (FA) alters the FA profile 
of animal tissues (Shingfield et  al., 2013). The 
omega-3 (n-3) FA eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) function as bioactive 
molecules and can activate the transcription factor 
PPARα (Clarke, 2001). This activation increases 
the transcription of lipolytic genes and decreases 
the transcription of lipogenic genes, potentially 
increasing the utilization of FA for energy in liver 
tissue, which yields more energy than other metab-
olizable nutrients (Clarke, 2001). Although there is 
evidence for similar effects in ruminants (Bionaz 
et al., 2012), less is known about the effects of EPA 
and DHA on liver and subcutaneous adipose tissue 
gene expression in ruminants than in nonruminants. 
In addition, recent work has indicated that when 
supplemented in the diet as calcium (Ca) salts, EPA 
and DHA may have differential effects in subcuta-
neous adipose tissue and liver tissue (Coleman 
et al., 2018a).
Fetal programming is the process through 
which stimuli during the development of a fetus 
have lifelong effects on offspring (Godfrey and 
Barker, 2001). Fatty acids are one nutrient that may 
have fetal programming effects when supplemented 
during gestation because maternal supplementation 
alters the FA that are transferred to the fetus (Noble 
et al., 1978; Garcia et al., 2014a). In dairy cattle, sup-
plementing multiparous cows with fats differing in 
FA profile [saturated fatty acids (SFA) vs. essential 
polyunsaturated fatty acids (PUFA)], but providing 
similar amounts of energy, increased birth weight 
compared with dams not supplemented with fat 
(Garcia et al., 2014a). The calves born from dams 
supplemented with SFA also had greater intakes 
and average daily gain through 60 d of age (Garcia 
et al., 2014b). In sheep, FA supplementation during 
gestation and lactation has been shown to affect 
offspring growth (Capper et al., 2006, 2007). When 
supplemented to dams during gestation, EPA and 
DHA alter offspring development through changes 
in metabolism in nonruminants (Mennitti et  al., 
2015), but little is known about their effects in ru-
minants. In beef cattle, supplementation of PUFA 
during the last third of gestation increased off-
spring BW compared with a diet with the same 
energy content but different FA profile (Marques 
et al., 2017). In sheep, supplementation of an en-
riched source of EPA and DHA during late gesta-
tion affected the FA profile of lamb plasma prior 
to weaning (Coleman et al., 2018a) and increased 
offspring performance during the finishing period 
(Carranza-Martin et al., 2018). However, the mech-
anisms behind these changes have not been eluci-
dated. In addition, supplementing sources of n-3 
FA to lambs during the finishing period alters the 
FA profile and gene expression of adipose and 
muscle tissue (Cooper et  al., 2004; Urrutia et  al., 
2015, 2016). However, there are no studies that 
evaluate the interaction of FA supplementation to 
dams during late gestation and to offspring during 
the finishing period and the effects on offspring FA 
metabolism.
Therefore, we hypothesized that supplementa-
tion of Ca salts enriched with EPA and DHA to 
finishing lambs increases the concentrations of 
EPA and DHA in liver and subcutaneous adipose 
tissue, increases mRNA concentration of lipo-
lytic genes, and decreases mRNA concentration 
of lipogenic genes in both tissues. In addition, we 
hypothesized that supplemental Ca salts enriched 
in EPA and DHA alter metabolism to a greater ex-
tent on lambs born from ewes supplemented with 
an enriched source of EPA and DHA during late 
gestation compared with lambs from ewes supple-
mented with a source of palmitic and oleic FA. 
The objective of this study was to evaluate the ef-
fect of supplementing Ca salts enriched with EPA 
and DHA on liver and adipose tissue FA profiles 
and gene expression in finishing lambs born from 
ewes supplemented with or without Ca salts en-




This research study was conducted at the 
Sheep Center of the Ohio Agricultural Research 
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and Development Center, Wooster, OH (IACUC 
#2016A00000013). Seventy Hampshire × Dorset 
cross lambs (38 females and 32 males) were used 
in a 2 × 2 factorial arrangement of treatments. The 
lambs were born from ewes that were fed diets con-
taining different Ca salts of FA during the last 50 
d of gestation (first main factor: dam supplementa-
tion, DS). During the finishing period, lambs were 
fed diets with Ca salts of different FA (second main 
factor: lamb supplementation, LS).
Details of the experimental procedures of ewes 
and lambs pre-weaning have been described previ-
ously (Coleman et  al., 2018a,b). Briefly, gestating 
ewes were blocked by BW and conception date into 
group pens with 3 animals per pen. The groups 
were randomly assigned to 1 of 2 treatments: 1) Ca 
salts of a palmitic FA distillate (PFAD) as a source 
of palmitic and oleic acids at 0.39% DM (EnerGII, 
Virtus Nutrition LLC, Corcoran, CA) and 2)  Ca 
salts of EPA + DHA at 0.39% DM (StrataG113, 
Virtus Nutrition LLC, Corcoran, CA) (Table 1). 
After lambing, supplementation was ended, ewes and 
lambs were housed in individual lambing jugs for 12 
to 24 h depending the time of the day they were born. 
After lambs had suckled from their dams, all ewes 
and lambs were placed onto pasture until weaning.
Details of the experimental animals and diet 
during the finishing period are fully described in the 
companion article (Carranza-Martin et al., 2018). 
Briefly, lambs were weaned at approximately 61 d 
of age and were then blocked by sex and size (large, 
medium, and small) based on initial finishing 
period BW and distributed into 28 pens (not evenly 
distributed with 2 or 3 lambs per pen). During the 
first 1.5 mo of the finishing period, the lambs were 
adapted to a high concentrate diet. After adapta-
tion, lambs were fed diets that included PFAD or 
EPA + DHA at 1.48% DM. The amount of FA 
supplementation used was chosen to guarantee an 
intake of 18 mg per kg of metabolic BW (BW0.75) 
of EPA and DHA. This dose was used based pre-
vious studies where metabolism was altered in hu-
mans (Bester et al., 2010). Calcium salts of PFAD 
were used as a control instead of a diet without fat 
to eliminate the confounding factor of diet energy 
density. Supplementation of the FA began after the 
adaptation period. Diets were formulated to meet 
or exceed NRC requirements for growing lambs 
(NRC, 2007) and contained 61.09% ground corn, 
11.08% soybean meal, 24.08% soy hull, and 1.94% 
mineral and vitamin mix.
The diets were fed for 42 d, at which point 
lambs were slaughtered at the Ohio State University 
Department of Animal Sciences Meat Science 
Laboratory. Liver and subcutaneous adipose 
tissue samples were obtained from 1 lamb per pen 
postmortem (within 15 min) and snap-frozen using 
liquid N2. Samples were stored at −80  °C until 
analysis. A  liver sample was not obtained from 1 
lamb from the small size block (DS:EPA + DHA; 
LS:PFAD).
Tissue Analyses
The FA composition of  liver and subcutaneous 
adipose tissue was determined using 300 mg (wet 
wt) of  liver tissue and 150  mg (wet wt) of  sub-
cutaneous adipose tissue as per previous methods 
(O’Fallon et  al., 2007) with slight modifications 
(Coleman et al., 2018a). Extraction of  RNA from 
liver and subcutaneous adipose tissue was per-
formed using a commercial lipid-specific extrac-
tion kit according to the manufacturer’s protocol 
(74804 RNeasy Lipid Tissue Mini Kit, Qiagen, 
Hilden, Germany). The RNA from all samples 
was quantified using UV spectroscopy (Nanodrop 
Technologies) and qualitatively assessed using 
a BioAnalyzer 2100 and RNA NanoChip assay 
(Agilent Technologies). Two subcutaneous adi-
pose tissue samples were not used for analysis due 
to RNA integrity numbers below 4.5. One sample 
was from DS:EPA + DHA and LS:PFAD, and 
the other one was from DS:PFAD and LS:EPA 
+ DHA. Gene expression was determined using 
Table 1. Fatty acid profile (%  of total FA) of fat 
supplements fed to pregnant ewes during the last 
50 d of gestation at 0.39% DM and to lambs during 
the finishing period at 1.48% DM
Fatty acid
Supplement1,2














1PFAD = EnerGII as a source of palmitic and oleic acids (Virtus 
Nutrition LLC, Corcoran, Ca); EPA + DHA = StrataG113 as a source 
of EPA and DHA (Virtus Nutrition LLC, Corcoran, Ca).
2Fatty acid profiles evaluated using the methods of Weiss and Wyatt 
(2003).
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a Nanostring nCounter XT Assay (Nanostring 
Technologies, Seattle, WA) and analyzed as de-
scribed previously (Coleman et al., 2018a) for 27 
genes (Table 2). These genes were chosen based on 
their involvement in FA uptake and release, FA 
synthesis and transcription factors that influence 
their expression, as well as genes for adipokines, 
hormone receptors, and inflammation (Lee et al., 
2010; Bionaz et al., 2013; Contreras et al., 2017). 
Five housekeeping target genes were measured: 
cyclophilin A, beta-actin, beta-2 microglobulin, 
glyceraldehyde 3-phosphate dehydrogenase and 
phosphoglycerate kinase 1. There was an effect of 
treatment on the amount of  mRNA for cyclophilin 
A, so it was removed and not included in the ana-
lysis and the data were only normalized to the 
geometric mean of  the other 4 housekeeping 
target genes using the nSolver Analysis Software 
3.0 (Nanostring Technologies, Seattle, WA).
Statistical Analyses
Data were analyzed as a randomized complete 
block design with a 2 × 2 factorial arrangement of 
treatments using the MIXED procedure (9.4, SAS 
Institute, Cary, NC) testing the fixed effects of dam 
treatment and lamb treatment and their interaction 
and the random effect of size (block). Pen was con-
sidered as the experimental unit. Sex and size (large, 
medium, and small) were included as blocks and 
removed when not significant (P > 0.05). Number 
of lambs at birth was included as a covariable and 
removed of the model because it was not signifi-
cant. Statistical analysis of gene expression data 
was performed using the normalized data. Least 
square means and SE were determined using the 
LSMEANS statement in the MIXED procedure. 
Significance was set at P ≤ 0.05, and tendencies 
were determined at P > 0.05 and P ≤ 0.10.
RESULTS AND DISCUSSION
The basal diet fed to ewes during late gesta-
tion (DS) was formulated to meet the requirements 
of ewes during late gestation (NRC, 2007) and in-
cluded the same amount of Ca salts. Lamb finishing 
diets (LS) were also formulated to meet or exceed 
nutrient requirements for growing lambs (NRC, 
2007) and included Ca salts at the same amount. 
Therefore, the dam and lamb treatment diets only 
differed in the FA profile of the Ca salts. Thus, re-
sults of this experiment should be associated with 
the potential effects of supplemental EPA and 
DHA vs. PFAD, rather than the effects of fat itself. 
Although we recognize that the FA profile of the Ca 
salt were quite different, there are a limited number 
of commercial products available to provide FA 
to ruminants. The Ca salt of EPA and DHA util-
ized was the only product available to provide EPA 
and DHA at the time of the present study and was 
chosen with the Ca salt of PFAD to compare the 
effects of EPA and DHA vs. C16:0 and C18:1. In 
addition, similar models have been used previously 
in sheep (Carranza-Martin et  al., 2018; Coleman 
et al., 2018a,b), beef cattle (Marques et al., 2017), 
Table 2. Gene names and GenBank accession 
number
































1LPL  =  lipoprotein lipase; ATGL  =  adipose triglyceride lipase; 
HSL  =  hormone-sensitive lipase; DGAT1  =  diacylglycerol 
acyltransferase 1; DGAT2  =  diacylglycerol acyltransferase 2; 
SCD  =  stearoyl-CoA desaturase; ELOVL2  =  elongation of very 
long chain fatty acid 2; ELVL4  =  elongation of very long chain 
fatty acid 4; ELOVL5  =  elongation of very long chain fatty acid 5; 
FABP4  =  fatty acid binding protein 4; FAS  =  fatty acid synthase; 
FATP1  =  fatty acid transport protein 1; GIP  =  glucose-dependent 
insulinotropic polypeptide; PPAR = peroxisome proliferator activated 
receptors; RXR  =  retinoid × receptor; COX-2  =  cyclooxygenase-2; 
5-LOX = 5-lipoxygenase; GAPDH = glyceraldehyde 3-phosphate de-
hydrogenase; PGK1 = phosphoglycerate kinase.
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and dairy cattle (Garcia et al., 2014b, 2016). To our 
knowledge, this is the first study to investigate the 
effects of maternal supplementation with an en-
riched source of FA during late gestation on lamb 
liver and subcutaneous adipose tissue FA profiles 
and gene expression during the finishing period, 
and the interaction of supplementing an enriched 
source of FA to dams and then to their offspring 
during the finishing period.
Liver FA Concentration
A significant LS effect was observed for the 
concentration of C16:0 in liver tissue where con-
centrations were lower with EPA + DHA vs. 
PFAD supplementation during the finishing period 
(P  <  0.01; Table 3). The greater concentration of 
C16:0 in liver tissue of lambs supplemented with 
PFAD during the finishing period is reflective of 
the greater dietary concentration of C16:0 in the Ca 
salt of PFAD compared with the Ca salt of EPA + 
DHA (Table 1). In addition, C16:0 is the primary 
product of FA synthesis by the enzyme FA synthase 
in mammals (Smith, 1994). Thus, the decrease in 
C16:0 with EPA + DHA supplementation during 
the finishing period may also indicate decreased FA 
synthesis in the liver.
Many of the C18:1 isomers were affected by 
LS during the finishing period. Concentrations of 
C18:1 cis-9 in liver tissue were greater with LS of 
PFAD (P < 0.01; Table 3). A significant LS effect 
was also observed for C18:1 trans-10 (P < 0.01) and 
C18:1 trans-11 (P  =  0.05), where concentrations 
were greater in the liver tissue of lambs that were 
supplemented with EPA + DHA compared with 
PFAD. In addition, a significant LS effect was ob-
served for C18:1 trans 6,8 (P < 0.01), C18:1 trans-9 
(P < 0.01), C18:1 trans-12 (P = 0.05), C18:1 cis-11 
(P  <  0.01), C18:1 cis-12 (P  =  0.04), C18:1 cis-13 
(P < 0.01), and C18:1 cis-15 (P < 0.01); concentra-
tions of all of these FA were greater in liver tissue 
with LS of PFAD vs. EPA + DHA. Also, we ob-
served a LS effect for the calculated C18:1 desaturase 
index, where the index was lower with LS of EPA 
+ DHA (P < 0.01). The greater concentrations of 
C18:1 cis-9 in liver tissue of lambs supplemented 
with PFAD during finishing period might be due 
to the greater concentration of this FA in the Ca 
salt of PFAD vs. the Ca salt of EPA + DHA (Table 
1). The FA C18:1 cis-9 can also be synthesized en-
dogenously from C18:0 via desaturation by the en-
zyme stearoyl-CoA desaturase (SCD; Nakamura 
and Nara, 2004), and the C18:1 desaturase index 
can be used as an indicator of C18:1 cis-9 synthesis, 
where a lower index is associated with lower SCD 
activity and therefore lower synthesis of C18:1 
cis-9 (Palmquist et  al., 2004). Thus, the decrease 
in the concentration of C18:1 cis-9, as well as its 
desaturase index suggest that LS of EPA + DHA 
may decrease FA synthesis in the liver compared 
with PFAD supplementation. This potential de-
crease in synthesis of C18:1 cis-9 with EPA + DHA 
supplementation during the finishing period is as-
sociated with changes in liver SCD expression, as 
will be described later. In addition, both EPA and 
DHA alter biohydrogenation, resulting in the ac-
cumulation of biohydrogenation intermediates, 
primarily accumulation of trans isomers (Bauman 
and Griinari, 2003). Thus, changes in C18:1 trans-
10, C18:1 trans-11 suggest that biohydrogenation 
was altered with supplementation of EPA + DHA 
vs. PFAD during the finishing period. Changes in 
other C18:1 isomers that were greater with PFAD 
supplementation during the finishing period may 
also be attributed to changes in biohydrogenation, 
as there is evidence that oleic acid may undergo 
cis/trans isomerization in the rumen, producing a 
variety of C18:1 intermediates (Kemp et al., 1984; 
Jenkins et al., 2006).
A DS effect was also observed for the C18:1 
desaturase index; the index was lower in liver tissue 
of lambs born from dams supplemented with EPA 
+ DHA during late gestation (P = 0.05). This sug-
gests that DS with EPA + DHA during late ges-
tation decreased the synthesis of C18:1 cis-9 in 
lamb liver tissue during the finishing period com-
pared with maternal supplementation with PFAD. 
We hypothesized that maternal EPA + DHA sup-
plementation would program offspring tissues to-
ward decreased expression of lipogenic genes and 
that these changes would lead to differences in 
synthesis of FA. The lack of differences in other 
C18:1 isomers between DS treatments is not unex-
pected. Although maternal supplementation of FA 
does alter the transfer of FA to the fetus (Noble 
et  al., 1978), supplementation of FA during late 
gestation alone would not directly alter rumen 
biohydrogenation pathways of the offspring.
The concentration of C18:2, linoleic acid, was 
significantly affected by LS (P  =  0.01) and was 
greater in the liver tissue of PFAD lambs, whereas 
the concentration of C18:3, linolenic acid, was 
greater in liver of EPA + DHA lambs (P < 0.01). 
The concentration of C18:2 cis-12, trans-10 was 
greater (P  <  0.01), whereas the concentration of 
C18:2 cis-9, trans-11 tended to be greater (P = 0.08) 
in the liver of PFAD lambs. The conjugated lino-
leic acid (CLA) desaturase index was also affected 
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Table 3. Liver fatty acid concentrations (% total fatty acid methyl esters1) of finishing lambs supplemented 
with Ca salts of EPA + DHA or palmitic fatty distillate acid (PFAD) at 1.48% and born from ewes supple-
mented with EPA + DHA or PFAD at 0.39% DM during the last 50 d of gestation2
Dam PFAD EPA + DHA  P-value3
Lamb PFAD EPA + DHA PFAD EPA + DHA SEM4 LS DS DS × LS
C12:0 0.04 0.06 0.02 0.05 0.02 0.16 0.37 0.67
C13:0 0.03 0.06 0.00 0.06 0.01 <0.01 0.11 0.22
C14:0 iso 0.02 0.03 0.00 0.05 0.02 0.05 0.99 0.11
C14:0 0.62 0.57 0.64 0.50 0.06 0.11 0.73 0.48
C14:1 0.09 0.05 0.08 0.03 0.02 0.01 0.37 0.47
C16:0 iso 0.13 0.15 0.16 0.17 0.02 0.20 0.08 0.61
C16:0 15.48 12.27 15.44 12.30 0.54 <0.01 0.99 0.94
C17:0 1.91 2.41 2.57 2.07 0.28 0.99 0.54 0.07
C17:1 0.79 0.27 0.96 0.24 0.10 <0.01 0.39 0.27
C18:0 21.86 20.12 22.09 21.95 0.84 0.21 0.17 0.28
C18:1 t6,8 0.44 0.24 0.44 0.22 0.06 <0.01 0.85 0.86
C18:1 t9 0.36 0.19 0.31 0.20 0.05 <0.01 0.65 0.49
C18:1 t10 3.75 6.37 2.98 5.56 0.84 <0.01 0.22 0.97
C18:1 t11 1.01 2.03 1.24 2.90 0.86 0.05 0.41 0.62
C18: t12 0.63 0.16 0.72 0.29 0.07 <0.01 0.09 0.80
C18:1 c9 17.94 9.00 16.60 4.76 1.46 <0.01 0.05 0.28
C18:1 c11 2.08 1.59 1.83 1.65 0.14 <0.01 0.40 0.14
C18:1 c12 0.18 0.07 0.23 0.14 0.05 0.04 0.18 0.86
C18:1 c13 0.55 0.18 0.50 0.20 0.04 <0.01 0.63 0.27
C18:1 c16 0.12 0.10 0.14 0.12 0.02 0.20 0.27 0.71
C18:1 c15 0.09 0.03 0.11 0.02 0.02 <0.01 0.70 0.19
C18:2 10.86 9.12 10.41 9.61 0.47 0.01 0.96 0.28
C20:0 0.23 0.23 0.29 0.24 0.03 0.34 0.17 0.31
C20:1 0.10 0.20 0.10 0.18 0.04 0.01 0.82 0.68
C18:3 0.26 0.36 0.25 0.37 0.04 <0.01 0.97 0.71
C18:2 c9,t11 0.24 0.19 0.22 0.17 0.03 0.08 0.57 0.91
CLA Other5 0.16 0.11 0.19 0.12 0.02 0.01 0.38 0.66
C18:2 c12,t10 0.21 0.12 0.23 0.15 0.03 <0.01 0.36 0.73
C21:0 0.24 0.15 0.22 0.15 0.03 <0.01 0.53 0.76
C22:0 0.19 0.71 0.38 0.93 0.18 <0.01 0.22 0.95
C20:3 n-6 1.40 0.60 1.21 0.46 0.20 <0.01 0.39 0.89
C20:3 n-3 0.15 0.12 0.16 0.10 0.01 <0.01 0.76 0.25
C22:1 0.08 0.15 0.09 0.17 0.01 <0.01 0.30 0.60
C20:4 11.42 5.28 11.49 5.93 0.40 <0.01 0.33 0.43
C20:5 0.57 4.83 0.52 5.29 0.23 <0.01 0.34 0.23
C24:0 0.16 0.16 0.17 0.22 0.02 0.30 0.14 0.20
C22:5 2.66 9.14 3.03 9.27 0.31 <0.01 0.38 0.67
C22:6 1.55 11.27 2.53 11.77 0.51 <0.01 0.12 0.61
Unidentified peaks 0.002 0.001 0.002 0.001 0.0001 <0.01 0.71 0.68
Total MUFA5 28.42 20.81 26.53 16.88 1.52 <0.01 0.05 0.47
Total PUFA5 29.48 41.13 30.26 43.26 1.30 <0.01 0.23 0.57
Total n-35 5.17 25.70 6.51 26.83 0.89 <0.01 0.14 0.90
Total n-65 24.32 15.44 23.73 16.41 0.71 <0.01 0.77 0.23
Total EPA and DHA 2.11 16.10 3.05 17.07 0.69 <0.01 0.14 0.98
Total saturated 42.10 38.06 43.21 39.86 0.93 <0.01 0.10 0.68
Total unsaturated 57.89 61.94 56.79 60.13 0.93 <0.01 0.10 0.68
14:1 desaturase index6 0.12 0.10 0.12 0.06 0.03 0.11 0.41 0.55
18:1 desaturase index6 0.45 0.30 0.43 0.17 0.04 <0.01 0.05 0.17
CLA desaturase index6 0.21 0.10 0.19 0.11 0.04 0.01 0.90 0.53
n-6/n-3 4.71 0.55 3.85 0.66 0.25 <0.01 0.05 0.01
CLA Total 0.61 0.42 0.64 0.44 0.08 0.004 0.68 0.95
1C15:0 iso and ante, C 15:0, C17:0 iso, C16:1 and C17:0 ante are not presented in the table because no differences due to DS, LS or DSxLS (P ≥ 
0.14), and we did not hypothesizes changes on those FA.
2PFAD = EnerGII as a source of palmitic and oleic acids (Virtus Nutrition LLC, Corcoran, Ca); EPA + DHA = StrataG113 as a source of ei-
cosapentaenoic acid (EPA) and docosahexaenoic acid (DHA; Virtus Nutrition LLC, Corcoran, Ca).
3P-values: DS = dam supplementation during the last 50 d of gestation; LS = lamb supplementation during the finishing period.
4SEM = most conservative SE for interaction was presented.
5CLA = conjugated linoleic acid; MUFA = monounsaturated fatty acids; PUFA = polyunsaturated fatty acids; n-3 = omega-3; n-6 = omega-6.
614:1 desaturase index = cis-9 C14:1/(C14:0 + cis-9 C14:1); 18:1 desaturase index = cis-9 C18:1/(C18:0 + cis-9 C18:1); CLA desaturase index = cis-
9, trans-11 C18:2/(cis-9, trans-11 C18:2 + trans-11 C18:1.
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by LS; the index was lowest in liver tissue of EPA 
+ DHA lambs (P = 0.01). The changes in linoleic 
and linolenic acid are due to the differences in the 
concentrations of these FA between the 2 Ca salts 
(Table 1). In addition, biohydrogenation of lino-
leic acid results in the production of CLA isomers 
such as C18:2 cis-9, trans-11 and C18:1 cis-12, 
trans-10 (Jenkins et al., 2008). Therefore, increases 
in CLA isomers in liver tissue suggest that the in-
creased linoleic acid in the Ca salt of PFAD may 
have modulated biohydrogenation pathways to-
ward production of CLA intermediates. The CLA 
isomer C18:2 cis-9, trans-11 can also be synthesized 
in the body from C18:1 tran-11 via desaturation 
by SCD (Palmquist et al., 2004). As with the other 
desaturase indices described earlier, a lower value 
for the CLA desaturase index indicates a decreased 
production of C18:2 cis-9, trans-11 (Palmquist 
et al., 2004). This change is another indicator that 
hepatic activity of SCD may have been decreased 
with LS of EPA + DHA.
Only one DS × LS interaction was observed 
for FA in liver tissue; the ratio of n-6 to n-3 FA 
(P = 0.01; Table 3) was lowest in lambs that were 
born from dams supplemented with PFAD during 
late gestation and were supplemented with EPA + 
DHA during the finishing period. Lambs with DS 
and LS of EPA + DHA were the next lowest ratio, 
whereas DS of EPA + DHA and LS of PFAD was 
next. The greatest n-6:n-3 ratio was observed in 
lambs with DS and LS of PFAD. Hepatic concen-
trations of EPA (C20:5) and DHA (C22:6) were in-
creased with LS of EPA + DHA vs. PFAD during 
the finishing period (P < 0.01). A significant LS ef-
fect was also observed for arachidonic acid (C20:4; 
AA) where concentrations in liver tissue were de-
creased with EPA + DHA vs. PFAD supplemen-
tation (P  <  0.01). The changes in the these FA 
contributed to the significant increase and decrease 
in the total n-3 (P < 0.01) and omega-6 (n-6) FA 
(P < 0.01), respectively, in liver with LS of EPA + 
DHA. However, DS did not affect (P ≥ 0.12) the 
concentrations of EPA, DHA, AA, total n-3, or 
total n-6 in lamb liver. Compared with a study by 
Demirel et al. (2004), the enrichment of EPA in liver 
tissue in the present study is lower, while enrichment 
of DHA in liver is similar. However, the differences 
in EPA and DHA enrichment between the present 
study and the aforementioned study by Demirel 
et al. (2004) are likely due to the fact that they sup-
plemented fish oil with formaldehyde-treated whole 
linseed oil—the linseed oil would have provided a 
source of linolenic acid that could have been used to 
synthesize EPA and DHA, helping to increase their 
concentrations in tissues. However, the enrichment 
of EPA and DHA in liver tissue was greater in the 
present study compared with dairy cows that were 
fed fish oil or a saturated rumen-inert fat (Ballou 
et  al., 2009). The greater concentrations observed 
with LS of EPA + DHA in our study is likely due to 
the use of a Ca salt of containing EPA and DHA, 
compared with the unprotected fish oil used by 
Ballou et al. (2009). To our knowledge, there are no 
other studies in ruminants investigating the effects 
of maternal supplementation with EPA + DHA 
on offspring liver tissue FA during the finishing 
period. However, our results suggest that maternal 
supplementation does not modulate the deposition 
of EPA and DHA in offspring liver tissue during 
the finishing period.
Subcutaneous Adipose Tissue FA Concentration
Lamb supplementation (P = 0.05) altered the 
concentrations of  C10:0, C12:0, and C14:0 in sub-
cutaneous adipose tissue; lambs supplemented with 
EPA + DHA had greater concentrations of  these 
FA in their subcutaneous adipose tissue compared 
with lambs supplemented with PFAD (Table 4). The 
FA C10:0, C12:0, and C14:0 may be synthesized 
de novo in mammalian tissues (Schönfeld and 
Wojtczak, 2016). Thus, the increases in these FA 
might be may indicate increased FA synthesis in 
subcutaneous adipose tissue with LS of  EPA + 
DHA. These results agree with previous data in 
our lab where the concentration of  C10:0 was in-
creased in subcutaneous adipose tissue of  ewes 
after 1 mo of supplementation with EPA + DHA 
at 0.39% DM during late gestation (Coleman et al., 
2018a). A  study by Cooper et  al. (2004) found 
that the percentages of  C14:0 and C16:0 in sub-
cutaneous adipose tissue were increased in lambs 
supplemented with fish oil or fish oil plus marine 
algae compared with supplementation of  linseed 
oil, protected linseed oil (PLS), or PLS plus algae. 
In addition, Demirel et  al. (2004) supplemented 
lambs with linseed, linseed plus fish oil, or Ca salts 
of  palm oil and observed that lambs supplemented 
with linseed + fish oil had the highest concentra-
tions of  C16:0. However, supplementation of  n-3 
FA in young bulls using whole ground linseed de-
creased concentrations of  C14:0, C15:0, and C16:0 
in adipose tissue compared with bulls given no 
linseed, suggesting lower FA synthesis (Corazzin 
et  al., 2013). In sheep, Urrutia et  al. (2015) ob-
served no difference in the concentrations of 
C12:0, C14:0, and C16:0 in subcutaneous adipose 
tissue with linseed or chia seed supplementation 
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Table 4. Subcutaneous adipose tissue fatty acid concentrations (% total fatty acid methyl esters1) of finishing 
lambs supplemented with Ca salts of EPA + DHA or palmitic fatty distillate acid (PFAD) at 1.48% and 
born from ewes supplemented with EPA + DHA or PFAD at 0.39% DM during the last 50 d of gestation2
Dam PFAD EPA + DHA P-value3
Lamb PFAD EPA + DHA PFAD EPA + DHA SEM4 LS DS DS × LS
C10:0 0.13 0.14 0.14 0.16 0.01 0.05 0.10 0.64
C12:0 0.11 0.16 0.17 0.18 0.03 0.05 0.01 0.13
C13:0 0.02 0.02 0.02 0.03 0.003 0.06 0.01 0.20
C14:0 2.56 2.94 2.83 3.34 0.27 0.05 0.13 0.75
C15:0 iso 0.09 0.11 0.10 0.12 0.01 0.05 0.20 0.60
C14:1 0.04 0.07 0.10 0.10 0.02 0.49 0.01 0.51
C16:0 22.99 23.24 22.51 23.82 0.74 0.25 0.94 0.43
C18:0 19.73 14.81 15.28 13.81 1.96 0.04 0.07 0.24
C18:1 t6,8 0.02 0.005 0.005 0.001 0.013 0.34 0.35 0.55
C18:1 t9 — 0.04 0.06 — 0.04 0.84 0.84 0.15
C18:1 t10 8.66 9.92 7.65 8.68 1.19 0.29 0.29 0.92
C18:1 t11 0.31 0.65 0.53 0.56 0.19 0.80 0.68 0.36
C18:1 t12 — 0.03 — — 0.01 0.19 0.19 0.19
C18:1 c9 27.84 28.81 33.03 30.25 1.99 0.47 0.01 0.14
C18:1 c11 1.04 1.5 1.09 1.11 0.06 0.06 0.50 0.12
C18:1 c12 0.22 0.14 0.18 0.16 0.02 0.05 0.68 0.14
C18:1 c13 0.08 0.08 0.07 0.09 0.02 0.60 0.93 0.63
C18:1 c16 0.04 0.05 0.04 0.04 0.02 0.57 0.70 0.76
C18:1 c15 0.08 0.07 0.08 0.10 0.02 0.81 0.60 0.33
C18:2 4.52 4.69 4.08 4.22 0.044 0.69 0.25 0.98
C20:0 0.08 0.07 0.05 0.05 0.01 0.60 0.02 0.53
C20:1 0.04 0.05 0.02 0.04 0.02 0.40 0.44 0.78
C18:3 0.34 0.46 0.46 0.48 0.05 0.23 0.25 0.47
C18:2 c9,t11 0.32 0.50 0.46 0.57 0.08 0.02 0.09 0.56
CLA other5 0.05 0.07 0.07 0.06 0.01 0.15 0.54 0.12
C18:2 c12,t10 0.07 0.06 0.06 0.05 0.01 0.19 0.09 0.73
C21:0 0.01 0.01 0.01 0.02 0.005 0.16 0.23 0.58
C22:0 0.01 0.02 0.003 0.02 0.005 <0.01 0.48 0.24
C20:3 n-6 0.02 0.05 0.04 0.03 0.02 0.44 0.88 0.20
C20:3 n-3 0.02 0.02 — 0.01 0.01 0.16 0.06 0.31
C22:1 0.02 0.01 0.04 0.04 0.02 0.75 0.33 0.82
C20:4 0.12 0.15 0.14 0.13 0.02 0.54 0.93 0.30
C20:5 0.01 0.17 0.02 0.11 0.02 <0.01 0.07 0.02
C24:0 0.003 0.02 0 0.01 0.01 0.14 0.37 0.55
C22:5 0.05 0.26 0.08 0.22 0.03 <0.01 0.85 0.14
C22:6 0.02 0.22 0.02 0.13 0.02 <0.01 0.07 0.04
Unidentified peaks 4.82 4.84 4.17 4.69 0.68 0.66 0.51 0.68
Total MUFA5 39.37 42.35 44.63 42.65 1.82 0.69 0.03 0.05
Total PUFA5 5.55 6.64 5.42 6.02 0.48 0.06 0.38 0.57
Total n-35 0.47 1.13 0.58 0.95 0.08 <0.01 0.58 0.04
Total n-65 5.07 5.51 4.84 5.06 0.44 0.40 0.39 0.79
Total EPA and DHA 0.03 0.39 0.04 0.25 0.04 <0.01 0.06 0.03
Total saturated 50.37 46.28 45.83 46.65 2.01 0.26 0.16 0.10
Total unsaturated 44.87 48.94 50.08 48.66 1.70 0.27 0.05 0.03
14:1 desaturase index6 0.02 0.02 0.03 0.03 0.01 0.90 0.01 0.23
18:1 desaturase index6 0.59 0.66 0.68 0.69 0.04 0.19 0.05 0.25
CLA desaturase index6 0.74 0.53 0.53 0.57 0.14 0.52 0.48 0.33
n-6/n-3 10.70 4.93 8.8 5.49 0.64 <0.01 0.11 0.01
CLA total 0.43 0.63 0.58 0.69 0.08 0.02 0.11 0.46
1C13:0 iso and ante, C14:0 iso, C15:0 ante, C 15:0, C10:0 iso, C17:0 iso, C16:1 and C17:0 ante, C17:0 and C17:1 are not presented in the table 
because no differences due to DS, LS or DSxLS (P ≥ 0.12), and we did not hypothesize changes on those FA.
2PFAD = EnerGII as a source of palmitic and oleic acids (Virtus Nutrition LLC, Corcoran, Ca); EPA + DHA = StrataG113 as a source of ei-
cosapentaenoic acid (EPA) and docosahexaenoic acid (DHA; Virtus Nutrition LLC, Corcoran, Ca).
3P-values: DS = dam supplementation during the last 50 d of gestation; LS = lamb supplementation during the finishing period.
4SEM = most conservative SE for interaction was presented.
5CLA = conjugated linoleic acid; MUFA = monounsaturated fatty acids; PUFA = polyunsaturated fatty acids; n-3 = omega-3; n-6 = omega-6.
614:1 desaturase index = cis-9 C14:1/(C14:0 + cis-9 C14:1); 18:1 desaturase index = cis-9 C18:1/(C18:0 + cis-9 C18:1); CLA desaturase index = cis-
9, trans-11 C18:2/(cis-9, trans-11 C18:2 + trans-11 C18:1.
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compared with no oilseed supplementation. Thus, 
the results of  the present and aforementioned 
studies suggest that marine FA sources may differ-
entially affect the concentrations of  FA with 16 or 
fewer carbons in subcutaneous adipose tissue com-
pared with other sources of  n-3 FA in ruminants. 
Omega-3 FA are typically thought to decrease 
lipogenic gene expression, leading to a potential 
decrease in FA synthesis (Clarke, 2001). Thus, the 
mechanism by which EPA and DHA in marine FA 
sources may potentially increase FA synthesis in 
subcutaneous adipose tissue is unknown but could 
be mediated by changes in gene expression. We 
have previously observed that lipogenic gene ex-
pression was increased in subcutaneous adipose 
tissue with supplementation of  0.39% (DM basis) 
of  Ca salts containing EPA and DHA (Coleman 
et al., 2018a). However, as will be discussed, in the 
present study, there were few changes in the mRNA 
expression in subcutaneous adipose tissue with LS 
of  EPA + DHA vs. PFAD. In addition, it is pos-
sible that the differences in FA synthesis could be 
related to biohydrogenation. Changes in tissue FA 
suggest that rumen biohydrogenation was altered 
with supplementation of  Ca salts. It is possible that 
the Ca salt containing EPA and DHA was more 
highly biohydrogenated than the Ca salt of  PFAD, 
which would have limited the amount of  EPA and 
DHA being absorbed and reaching adipose tissue 
to exert the expected effects compared with palm-
itic and oleic acids.
Dam supplementation also altered the concen-
trations of FA with less than 16 carbons in lamb 
subcutaneous adipose tissue. Lambs born from 
ewes supplemented with EPA + DHA during late 
gestation had greater concentrations of C12:0 
(P = 0.01) in their adipose tissue, while they tended 
to have greater concentrations of C10:0 (P = 0.10) 
than lambs born for PFAD ewes. To our know-
ledge, there are no other studies investigating the 
effects of maternal FA supplementation on lamb 
subcutaneous adipose tissue FA during the fin-
ishing period. As mentioned earlier, C10:0 and 
C12:0 may be synthesized in tissues. Thus, these re-
sults suggest that DS with EPA + DHA during late 
gestation may program lamb subcutaneous adipose 
tissue toward increased FA synthesis. However, as 
will be discussed in the gene expression section, the 
mechanism behind a potential increase in FA syn-
thesis in adipose tissue with DS of EPA + DHA is 
unclear. Also, due to the design of the experiment 
we cannot confirm if  these changes started during 
the fetal or growing stages.
Concentrations of  C18:0 were greater in sub-
cutaneous adipose tissue of  lambs with LS of 
PFAD (P = 0.04). Fewer C18:1 isomers were af-
fected by LS in adipose tissue compared with liver 
tissue. The concentration of  C18:1 cis-11 tended 
(P = 0.06) to be greater in adipose tissue of  lambs 
that were supplemented with EPA + DHA com-
pared with PFAD. Concentrations of  C18:1 cis-
12, however, were greater in adipose tissue of 
lambs that were supplemented with PFAD during 
the finishing period (P = 0.05). The concentration 
of  C18:2 cis-9, trans-11 was also greater (P = 0.02) 
in the adipose tissue of  lambs supplemented with 
EPA + DHA. This contributed to the greater con-
centration of  total CLA isomers in subcutaneous 
adipose tissue of  EPA + DHA lambs (P = 0.02). 
Because the FA C18:0 is the end product of  com-
plete biohydrogenation in the rumen (Jenkins and 
Bridges, 2007), the greater concentration of  C18:0 
in subcutaneous adipose tissue of  lambs supple-
mented with PFAD may be indicative of  more 
complete biohydrogenation of  the FA compared 
with EPA + DHA supplementation. This change 
in C18:0 with LS of  EPA and DHA was also ob-
served in muscle tissue, where C18:0 tended to 
be decreased with LS of  EPA + DHA vs. PFAD 
(Carranza-Martin et al., 2018). While not signifi-
cant, a numerical decrease in C18:0 (P = 0.21) was 
also observed in liver tissue with LS of  EPA + 
DHA in the present study. The response of  total 
CLA isomers in subcutaneous adipose tissue is 
opposite of  liver tissue, where the concentration 
of  total CLA isomers was greater with LS of 
PFAD compared with EPA + DHA. The reason 
for the different response between the 2 tissues is 
not known but may be attributed to a difference in 
storage vs. metabolism between adipose tissue and 
liver tissue.
Only one C18:1 isomer was significantly af-
fected by DS in subcutaneous adipose tissue, with 
concentrations of C18:1 cis-9 being greater in lambs 
that were born from ewes supplemented with EPA 
+ DHA vs. lambs from ewes supplemented with 
PFAD (P = 0.01). In addition, the C18:1 desaturase 
index was greater in subcutaneous adipose tissue 
when dams were supplemented with EPA + DHA 
during late gestation (P = 0.05). Thus, our results 
suggest that supplementing ewes with EPA + DHA 
during late gestation may increase the synthesis of 
C18:1 cis-9 in lamb subcutaneous adipose tissue 
during the finishing period. This is in line with the 
potential increase in FA synthesis discussed earlier 
for FA with less than 16 carbons. In addition, the 
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lack of changes in other C18:1 isomers due to DS 
is not unexpected since maternal supplementation 
during late gestation alone would have little influ-
ence on offspring rumen biohydrogenation path-
ways as described earlier.
A DS × LS interaction (P ≤ 0.04) was observed 
for EPA and DHA concentration, where EPA + 
DHA supplementation of lambs during the fin-
ishing period increased the concentrations of EPA 
and DHA in subcutaneous adipose tissue, but the 
increase was greatest for lambs born from PFAD 
supplemented ewes vs. EPA + DHA supplemented 
ewes (Table 4). This same DS × LS interaction (P 
≤ 0.04) was observed for the concentration of total 
n-3 FA, and the n-6:n-3 FA ratio. This interaction 
between DS and LS is opposite of what we hy-
pothesized. It is possible that the lambs with DS 
and LS of EPA + DHA were not synthesizing as 
much EPA and DHA in adipose tissue compared 
with the other lambs since they were receiving a 
steady supply of these FA. As will be described in 
the gene expression section, this assumption is sup-
ported by changes in mRNA expression. Although 
EPA and DHA were enriched in subcutaneous adi-
pose tissue in the present study, concentrations of 
these FA were much lower in this depot compared 
with liver tissue. The concentrations of EPA and 
DHA in subcutaneous adipose tissue are also lower 
than the concentrations in muscle tissue of lambs 
in this study (Carranza-Martin et  al., 2018). This 
is likely attributed to the fact that PUFA are pref-
erentially incorporated into phospholipids in ru-
minants (Ashes et al., 1992) and phospholipids are 
more abundant in intramuscular fat. It is possible 
that EPA and DHA were preferentially incorpor-
ated into intramuscular fat, which may explain why 
concentrations of these 2 FA were greater in muscle 
tissue (Carranza-Martin et  al., 2018). Liver tissue 
has also been characterized as having a greater 
concentration of phospholipids compared with 
other tissues in ruminants (Bermingham et  al., 
2018), which may explain why liver tissue had the 
greatest concentrations of EPA and DHA of the 
3 tissues. However, it should be noted that the in-
creases in EPA and DHA in liver and muscle tissue 
were only due to LS, and not DS (Carranza-Martin 
et al., 2018). This suggests that subcutaneous adi-
pose tissue may have unique features that allowed 
an interaction of DS and LS to modulate concen-
trations of EPA and DHA. We speculate that the 
changes observed in adipose tissue with both DS 
and LS may be related to its function as the pri-
mary site of FA synthesis in ruminants (Bergen and 
Mersmann, 2005).
Concentration of mRNA in Liver Tissue
Fatty acid uptake and release genes in liver. 
There were no DS × LS interactions observed for 
the mRNA expression of genes related to FA up-
take and release (P > 0.10; Table 5). Expression of 
lipoprotein lipase (LPL) was greater in liver tissue 
of lambs supplemented with PFAD during the fin-
ishing period (P = 0.01). Lipoprotein lipase is in-
volved in the hydrolysis of FA from lipoproteins 
for uptake by cells. The change in LPL suggests 
that supplementation of EPA and DHA might de-
creased uptake of FA from lipoproteins by the liver 
compared with supplementation of palmitic and 
oleic acid. Lipoprotein lipase is a lipogenic enzyme 
due to its role in uptake of FA, thus the decrease 
in LPL expression with LS of EPA + DHA com-
pared with PFAD fits with our hypothesis that lipo-
genic gene expression would be decreased by EPA 
and DHA supplementation. Data on the effects of 
supplementing n-3 FA on liver gene expression in 
ruminants are limited. Most studies in ruminants 
have examined the effects of supplementing sources 
of n-3 FA, such as EPA and DHA, on muscle 
and adipose tissue gene expression. However, in 
lactating dairy cows, hepatic LPL expression was 
not altered by supplementation with 200 g/d of fish 
oil or microalgae compared with no lipid supple-
mentation (Vahmani et  al., 2014). Another study 
in lactating dairy cows by Hiller et  al. (2013) ob-
served no difference in LPL when algae was supple-
mented with sunflower oil or linseed oil compared 
with SFA supplementation. The difference in the 
response of LPL in our study vs. the studies by 
Hiller et al. (2013) and Vahmani et al. (2014) could 
be attributed to differences in physiological status 
between lactating cows and growing lambs. The use 
of oil and algae, which may be biohydrogenated at 
a greater rate than Ca salts, may also be a factor in 
the differences between studies.
Dam supplementation altered hepatic hormone-
sensitive lipase (HSL), with greater expression in 
lambs born from EPA + DHA ewes than lambs 
born from PFAD ewes (P = 0.01; Table 5). In add-
ition, DS of EPA + DHA tended (P = 0.09) to in-
crease the expression of fatty acid binding protein 
4 (FABP4) in finishing lamb liver tissue compared 
with DS of PFAD. These changes in HSL and 
FABP4 mRNA concentration suggest that maternal 
supplementation of EPA and DHA may program 
lamb liver tissue toward greater lipolysis. The fact 
that both of these were altered in the same direction 
supports the hypothesis that there is a direct inter-
action between FABP4 and HSL, where FABP4 
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may facilitate lipolysis (Hotamisligil and Bernlohr, 
2015). However, there were no differences between 
DS treatments in plasma NEFA concentrations to 
indicate that FA mobilization was increased by DS 
of EPA + DHA (Carranza-Martin et al., 2018).
Fatty acid synthesis genes in liver. No DS × LS 
interactions were observed for genes related to FA 
synthesis in liver tissue (P > 0.10; Table 5). Hepatic 
expression of fatty acid synthase (FAS) was lower 
(P < 0.01; Table 5) with LS of EPA + DHA. Lambs 
supplemented with PFAD during the finishing 
period had greater (P  <  0.01) mRNA expression 
of SCD, Δ5-desaturase, and Δ6-desaturase com-
pared with lambs supplemented with EPA + DHA. 
Elongation of very long chain fatty acid 5 (ELOVL5) 
also tended to be greater (P = 0.06) in liver tissue 
of lambs with LS of PFAD. No differences were 
observed in the expression of other lipogenic genes 
in liver tissue between LS or DS (P > 0.10; Table 5): 
elongation of very long chain fatty acid 2 (ELOVL2), 
elongation of very long chain fatty acid 4 (ELOVL4), 
diacylglycerol acyltransferase 1 (DGAT1), and 
diacylglycerol acyltransferase 2 (DGAT2). Fatty acid 
synthase is used to synthesize SFA up to 16 car-
bons in length. The elongation enzyme ELOVL5 is 
utilized to produce longer chain FA that are typic-
ally polyunsaturated (Tvrdik et al., 2000). As men-
tioned earlier, the enzyme SCD introduces a double 
bond at the ninth carbon from the carboxyl end of 
FA with 12 to 19 carbons, whereas the Δ5- and Δ6-
desaturases add double bonds at the fifth and sixth 
carbons, respectively (Nakamura and Nara, 2004). 
Therefore, the decreased expression of FAS, SCD, 
Δ5-desaturase, Δ6-desaturase, and ELOVL5 in liver 
tissue with LS of EPA + DHA suggests FA syn-
thesis was potentially decreased compared with LS 
of PFAD. This is supported in part by the changes 
in medium chain FA and desaturase indices for 
SCD in liver tissue with LS of EPA + DHA as de-
scribed earlier. The alterations in lipogenic genes 
observed in the present study are consistent with 
previous studies. Hiller et al. (2013) supplemented 
dairy cows with a saturated rumen-protected fat, 
sunflower oil with algae, and linseed oil with algae 
and observed decreases in the liver tissue expression 
Table 5. Relative mRNA expression in liver tissue of finishing lambs supplemented with Ca salts of EPA 
+ DHA or palmitic fatty distillate acid (PFAD) at 1.48% and born from ewes supplemented with EPA + 
DHA or PFAD at 0.39% DM during the last 50 d of gestation1
Dam PFAD EPA + DHA P-value2
Lamb PFAD EPA + DHA PFAD EPA + DHA SEM4 LS DS DS × LS
Item3         
5-LOX 19.98 15.16 17.87 16.38 1.88 0.04 0.77 0.25
ATGL 337.47 316.94 348.54 402.09 55.78 0.74 0.35 0.46
COX-2 35.65 47.74 49.13 43.26 8.16 0.64 0.52 0.19
Δ5-desaturase 2,186.21 1,010.13 2,172.50 1,173.61 218.95 <0.01 0.68 0.61
Δ6-desaturase 3,630.38 1,557.30 3,540.81 1,563.17 414.84 <0.01 0.91 0.90
DGAT1 391.60 338.52 471.02 466.36 69.55 0.64 0.11 0.69
DGAT2 664.13 756.79 750.12 748.65 93.87 0.59 0.64 0.57
ELOVL2 168.73 155.40 210.40 155.63 34.09 0.27 0.49 0.50
ELOVL4 17.27 14.64 17.26 22.28 3.01 0.63 0.14 0.13
ELOVL5 3,037.87 2,466.29 3,029.02 2,893.95 207.59 0.06 0.27 0.24
FABP4 14.32 15.02 22.24 23.29 5.17 0.85 0.09 0.97
FAS 506.94 248.18 563.97 320.86 71.04 <0.01 0.31 0.90
FATP1 19.58 22.00 24.21 22.17 4.20 0.96 0.52 0.55
HSL 12.23 13.07 18.18 16.53 1.94 0.82 0.01 0.46
LPL 48.32 40.37 59.30 37.22 6.77 0.01 0.46 0.17
SCD 3,673.38 1,373.02 3,464.32 1,170.47 225.78 <0.01 0.31 0.99
1PFAD = EnerGII as a source of palmitic and oleic acids (Virtus Nutrition LLC, Corcoran, Ca); EPA + DHA = StrataG113 as a source of ei-
cosapentaenoic acid (EPA) and docosahexaenoic acid (DHA; Virtus Nutrition LLC, Corcoran, Ca).
2P-values: DS = Dam supplementation during the last 50 d of gestation; LS = Lamb supplementation during the finishing period.
3ATGL = adipose triglyceride lipase; COX-2 = cyclooxygenase-2; DGAT1 = diacylglycerol acyltransferase 1; DGAT2 = diacylglycerol acyltransferase 
2; ELOVL2 = elongation of very long chain fatty acid 2; ELVL4 = elongation of very long chain fatty acid 4; ELOVL5 = elongation of very long 
chain fatty acid 5; FABP4 = fatty acid binding protein 4; FAS = fatty acid synthase; FATP1 = fatty acid transport protein 1; HSL = hormone-sensitive 
lipase; LPL = lipoprotein lipase; SCD = stearoyl-CoA desaturase. Concentration of glucose-dependent insulinotropic polypeptide receptor, insulin 
receptor, ghrelin receptor, peroxisome proliferator-activated receptors α, β/δ, and γ, retinoid × receptor are not presented in the table because no 
differences due to DS, LS, or DS × LS (P ≥ 0.15).
4SEM = most conservative SE for interaction was presented.
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of  FAS, SCD, Δ5-desaturase, and Δ6-desaturase 
when the oils with algae were fed. In another study 
with dairy cattle, supplementation of fish oil or 
microalgae decreased expression of FAS, SCD, 
Δ5-desaturase, Δ6-desaturase in liver tissue com-
pared with no fat supplementation (Vahmani et al., 
2014). In dairy goats, supplementation of sun-
flower oil and fish oil together decreased expression 
of SCD and Δ6-desaturase in liver tissue compared 
with sunflower oil alone (Toral et al., 2013). Care 
should be taken in comparing the present study to 
the aforementioned studies due to the differences in 
the sources of EPA and DHA. However, it seems 
that supplementing a source of EPA and DHA has 
the expected effects of decreasing lipogenic gene ex-
pression in liver tissue across ruminant species.
There were no differences (P ≥ 0.11; Table 5) be-
tween DS treatment for any of the measured genes 
in liver tissue that are involved in FA synthesis. 
Although not significant, the mRNA expression 
of these genes, except for SCD, was numerically 
greater in liver tissue of lambs born from ewes sup-
plemented with EPA + DHA during late gestation. 
This is opposite of what we hypothesized, however, 
a similar effect of EPA and DHA on increasing ex-
pression of lipogenic genes was observed in sub-
cutaneous adipose tissue of the dams of the lambs 
for this study (Coleman et  al., 2018a). The dose 
of EPA and DHA supplemented to the dams was 
low at 0.39% DM and the concentrations of EPA 
and DHA in the lamb’s plasma at birth were not 
different between lambs born from EPA + DHA 
supplemented ewes and those born from PFAD 
supplemented ewes (Coleman et al., 2018a). Thus, 
it is possible that this dose was not high enough to 
result in large amounts of EPA and DHA transfer 
and deposition to exert the expected effects via 
PPARα in liver tissue during fetal development.
Transcription factor genes in liver. Hepatic ex-
pression of all 3 PPAR isoforms, α, γ and β/δ, and 
the retinoid × receptor alpha (RXRα) was not dif-
ferent between DS during late gestation (P ≥ 0.77), 
or LS during the finishing period (P ≥ 0.15) and 
there were no DS × LS interactions (P ≥ 0.32). The 
lack of changes in genes for transcription factors is 
likely due to the fact that these transcription factors 
are not highly transcriptionally regulated. However, 
long-chain FA have been observed to alter expres-
sion of PPAR isoforms in ruminant liver tissue in 
vitro (Bionaz et al., 2013). Thus, we hypothesized 
that PPARα expression and activation would be in-
creased by supplementation with EPA and DHA in 
maternal and finishing diets. The lack of changes 
in the mRNA expression of genes for transcription 
factors agrees with previous in vivo studies in ru-
minants. The expression of PPARγ and PPARα in 
liver tissue of dairy goats was unaffected by sup-
plementation of fish oil with sunflower oil vs. sup-
plementation of sunflower oil alone (Toral et  al., 
2013). Vahmani et al. (2014) also observed no dif-
ference in the expression of PPARγ in liver tissue 
of lactating dairy cows supplemented with fish oil 
or microalgae compared with a nonfat control. 
Another study in lactating dairy cattle by Hiller 
et al. (2013) also observed no difference in hepatic 
PPARγ expression when sunflower oil with algae, 
linseed oil with algae, or a rumen-protected satur-
ated fat were fed.
Although the expression of PPARα in liver 
tissue of finishing lambs in the present study was 
not altered by LS, it should be noted that there is in-
dication that PPARα activation was increased. This 
is indicated by the changes observed in FAS, SCD, 
Δ5-desaturase, Δ6-desaturase, LPL, and ELOVL5 in 
liver tissue with LS of EPA + DHA vs. PFAD, which 
are genes that have been identified as potential tar-
gets of PPAR in ruminants (Bionaz et  al., 2013). 
There is only limited indication that DS may have 
also increased PPARα activation in offspring liver 
because HSL alone was altered with DS of EPA + 
DHA vs. PFAD. Thus, it seems that finishing diet 
supplementation of EPA and DHA may have had a 
greater effect on PPARα activation compared with 
maternal supplementation. As mentioned earlier, 
it is possible that the low dose of 0.39% DM of 
Ca salts of EPA and DHA used in the maternal 
diets was too small to illicit the expected effects on 
PPARα activation in offspring liver tissue.
Hormone receptor genes in liver.  There were 
also no differences (P ≥ 0.16) in the expression 
of ghrelin receptor, insulin receptor, or glucose-
dependent insulinotropic polypeptide (GIP) receptor 
in liver tissue between LS or DS. The lack of dif-
ferences in the expression of the hormone recep-
tors in liver tissue was associated with the lack of 
change in plasma glucose and NEFA concentration 
with DS or LS reported in the companion article 
(Carranza-Martin et  al., 2018). However, supple-
mentation with increasing doses of Ca salts con-
taining EPA and DHA to pregnant ewes during late 
gestation increased plasma glucose and decreased 
plasma ghrelin concentration (Nickles et al., 2018).
Inflammatory response genes in liver. The ex-
pression of 5-lipoxygenase (5-LOX) was decreased 
(LS: P = 0.04) in liver tissue of lambs supplemented 
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with EPA + DHA compared with PFAD during the 
finishing period. The enzyme 5-LOX functions in 
the production of leukotrienes from FA. Both EPA 
and DHA may potentially reduce the expression 
of inflammatory response genes, such as 5-LOX 
via signaling through transcription factors, such as 
PPAR, which may inhibit nuclear factor kappa B 
(NF-kB; Lee et al., 2010). The nuclear factor NF-kB 
signals cytokine that often produces inflammatory 
responses (Sordillo, 2016). Therefore, the decrease 
in mRNA expression of 5-LOX with LS of EPA + 
DHA compared with PFAD is potentially benefi-
cial at reducing the severity of an inflammatory re-
sponse in the liver.
There were no differences (P ≥ 0.37; Table 
5) in the mRNA expression of 5-LOX or 
cyclooxygenase-2 (COX-2) in liver tissue between 
DS treatments. The lack of differences in the ex-
pression of these genes in liver tissue due to ma-
ternal FA supplementation could be related to the 
fact the dose of EPA and DHA was too low to re-
sult in changes in the expression of these in liver 
tissue or that DS does not modulate the expression 
of these genes in liver tissue. Even though the tar-
geted dose of 18 mg/kg metabolic BW was the same 
for both ewes and lambs, the lambs were directly 
consuming the FA during the finishing period, ra-
ther than receiving them through placental transfer. 
The direct consumption during the finishing period 
could explain why changes were observed in liver 
tissue expression of inflammatory response genes 
with LS and not DS. In addition, to our knowledge, 
the ewes were not under inflammatory stress during 
the experiment and their plasma concentrations of 
prostaglandins were not different between treat-
ments (Coleman et al., 2018a). Thus, the fetus was 
not exposed to an inflammatory environment that 
would potentially alter and program liver mRNA 
expression of inflammatory response genes.
Concentration of mRNA in Subcutaneous 
Adipose Tissue
Fatty acid uptake and release genes in subcuta-
neous adipose tissue. A tendency for a DS × LS 
interaction (P  =  0.08; Table 6) was observed for 
HSL in subcutaneous adipose tissue where lambs 
with DS and LS of EPA + DHA had the lowest 
expression of HSL compared with the other dam 
and lamb treatments. Due to the role of HSL in 
triglyceride breakdown, the DS × LS interaction 
observed for HSL expression in subcutaneous 
adipose tissue might suggest that lipolysis was de-
creased in lambs with DS and LS of EPA + DHA. 
This interaction is opposite of what we hypothe-
sized would occur; however, this change fits with 
gene expression changes in the dam’s subcutaneous 
adipose tissue; dams supplemented with EPA + 
DHA had increased expression of lipogenic genes 
(Coleman et  al., 2018a). The changes in expres-
sion of HSL between adipose and liver tissue seem 
contradictory because the mRNA concentration of 
HSL increased with DS of EPA + DHA compared 
with PFAD. However, the expression of HSL was 
much greater in subcutaneous adipose tissue com-
pared with liver tissue, suggesting that the function 
of the gene is tissue specific, which may be why the 
response is different between the 2 tissues.
Fatty acid synthesis genes in subcutaneous adi-
pose tissue. A DS × LS interaction (P = 0.01; Table 
6) was observed for ELOVL2 where lambs that were 
born from DS of EPA + DHA and LS of EPA + 
DHA had the lowest expression of ELOVL2 in adi-
pose tissue. The enzyme ELOVL2 may be used in the 
synthesis of EPA and is utilized to synthesize DHA 
(Guillou et  al., 2010). Thus, changes in ELOVL2 
mRNA expression suggest that synthesis of EPA 
and DHA may have been decreased in lambs with 
DS and LS of EPA + DHA. It is possible that the 
expression of ELVOL2 was downregulated to limit 
the production of EPA and DHA due to the steady 
supply of these FA both prenatally and during the 
finishing period. This potential decrease in EPA 
and DHA synthesis may also explain why lambs 
with DS and LS of EPA + DHA did not have the 
greatest concentrations of EPA and DHA in their 
adipose tissue compared with the other DS and LS 
combinations. The lack of LS effects on genes for 
FA synthesis contrasts with the effects observed in 
the dam’s subcutaneous adipose tissue when they 
were supplemented with the same dose of EPA and 
DHA at 18 mg/kg of metabolic BW; dams supple-
mented with EPA + DHA had increased expression 
of FAS and DGAT2, potentially increasing lipogen-
esis (Coleman et al., 2018a). In addition, the lack of 
LS or DS effects on the expression of genes for FA 
synthesis does not explain the mechanism by which 
synthesis of medium chain FA in subcutaneous adi-
pose may have been increased by of EPA + DHA 
vs. PFAD. It is possible that protein expression was 
altered, even if  mRNA was not, to result in changes 
in FA synthesis. However, protein expression was 
not measured in this study to support this assump-
tion. In addition, compared with liver tissue, there 
were fewer changes in the mRNA expression of 
genes related to FA synthesis in subcutaneous adi-
pose tissue. This difference in expression between 
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tissues could be associated with the greater meta-
bolic activity of the liver and its role in lipid metab-
olism, compared with the role of adipose tissue in 
lipid storage and synthesis.
Transcription factor genes in subcutaneous adi-
pose tissue. As in liver tissue, expression of all 3 
PPAR isoforms α, γ and β/δ, and RXRα was not 
different (P ≥ 0.20; Table 6) in subcutaneous adi-
pose tissue between DS or LS and there were no DS 
× LS interactions. In accordance with the present 
study, we also observed no differences in the ex-
pression of genes for transcription factors in the 
subcutaneous adipose tissue of the dams used for 
this study (Coleman et  al., 2018a). We hypothe-
sized that PPARα activation and expression could 
be increased by supplementation with EPA and 
DHA and would increase the expression of lipo-
lytic genes and decrease the expression of lipogenic 
genes. Although there is evidence of PPARα acti-
vation in liver tissue in the present study via LS and 
DS, there were few changes in subcutaneous adi-
pose tissue gene expression to suggest that PPARα 
could be activated there. The lack of differences 
in lipolytic gene expression in subcutaneous adi-
pose tissue in the present study could be related to 
differences in the expression of PPARs across tis-
sues, as PPARα was greatest in liver and PPARγ 
Table 6. Relative mRNA expression in subcutaneous adipose tissue of finishing lambs supplemented with 
Ca salts of EPA + DHA or palmitic fatty distillate acid (PFAD) at 1.48% and born from ewes supple-
mented with EPA + DHA or PFAD at 0.39% DM during the last 50 d of gestation1
Dam PFAD EPA + DHA P-value2
Lamb PFAD EPA + DHA PFAD EPA + DHA SEM3 LS DS Ds × LS
Item4         
5-LOX 16.37 19.28 13.65 14.96 4.194 0.58 0.37 0.84
ATGL 1,628.63 1,324.04 1,195.24 1,664.91 290.39 0.76 0.86 0.16
Adiponectin 97,006 91,368 116,823 81,843 12,424 0.07 0.64 0.20
COX-2 118.38 193.06 225.68 131.82 86.97 0.90 0.77 0.30
Δ5-desaturase 196.49 200.31 197.51 175.50 27.47 0.72 0.64 0.61
Δ6-desaturase 121.82 129.67 132.15 113.53 20.25 0.77 0.88 0.48
DGAT1 569.16 585.64 595.82 824.43 185.58 0.46 0.44 0.53
DGAT2 12,682 12,404 15,900 12,369 2277 0.37 0.45 0.44
ELOVL2 30.50 35.75 35.88 27.42 3.043 0.51 0.55 0.01
ELOVL4 63.70 60.01 65.35 55.41 5.330 0.17 0.76 0.53
ELOVL5 2015.85 2,253.16 2,213.47 1,703.84 321.37 0.64 0.52 0.21
FABP4 237,594 229,692 252,470 195,327 22,119 0.12 0.63 0.23
FAS 35,407 29,439 32,912 32,719 6,282 0.59 0.95 0.62
FATP1 27.22 26.97 21.04 25.42 5.67 0.70 0.47 0.67
Ghrelin receptor 19.92 13.92 17.00 26.89 5.454 0.70 0.32 0.12
GIP receptor 67.98 66.99 62.78 56.04 3.897 0.20 0.01 0.34
HSL 6,115.46 6,345.70 7,395.30 4,725.23 869.75 0.14 0.83 0.08
Insulin receptor 469.21 483.81 439.52 430.10 48.86 0.95 0.36 0.79
Leptin 477.09 395.68 574.91 366.52 85.48 0.08 0.66 0.42
LPL 35,794 36,538 40,834 33,865 5,337 0.53 0.81 0.44
PPARα 213.28 201.01 211.47 198.53 16.89 0.42 0.89 0.98
PPARβ/δ 125.38 113.35 110.51 140.74 17.72 0.58 0.70 0.20
PPARγ 4,090.70 4,371.56 4,565.76 4,045.50 389.57 0.72 0.83 0.26
Resistin 2.78 4.92 2.91 4.20 1.15 0.07 0.75 0.65
RXRα 114.91 111.57 121.19 130.56 17.39 0.85 0.43 0.69
SCD 17,213 19,746 22,287 16,138 4,438 0.65 0.86 0.29
1PFAD = EnerGII as a source of palmitic and oleic acids (Virtus Nutrition LLC, Corcoran, Ca); EPA + DHA = StrataG113 as a source of ei-
cosapentaenoic acid (EPA) and docosahexaenoic acid (DHA; Virtus Nutrition LLC, Corcoran, Ca).
2P-values: DS = Dam supplementation during the last 50 d of gestation; LS = Lamb supplementation during the finishing period.
3SEM = most conservative SE for interaction was presented.
45-LOX  =  5-lipoxygenase; ATGL  =  adipose triglyceride lipase; COX-2  =  cyclooxygenase-2; DGAT1  =  diacylglycerol acyltransferase 1; 
DGAT2 = diacylglycerol acyltransferase 2; ELOVL2 = elongation of very long chain fatty acid 2; ELVL4 = elongation of very long chain fatty acid 
4; ELOVL5 = elongation of very long chain fatty acid 5; FABP4 = fatty acid binding protein 4; FAS = fatty acid synthase; FATP1 = fatty acid trans-
port protein 1; GIP = glucose-dependent insulinotropic polypeptide; HSL = hormone-sensitive lipase; LPL = lipoprotein lipase; PPAR = peroxisome 
proliferator-activated receptor; RXR = retinoid × receptor; SCD = stearoyl-CoA desaturase.
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was greatest in adipose tissue. In addition, much of 
the basis for what is known about PPARα is based 
on effects in liver tissue (Clarke, 2001). Although 
there is also evidence from rodent models (Flachs 
et al., 2005), as well as in vitro models with adipo-
cytes (Guo et al., 2005), that EPA and DHA may 
increase the potential for FA oxidation in adipose 
via gene expression changes, it is possible that ef-
fects on gene expression may not be as potent in 
adipose tissue compared with liver. The effects of 
PPARγ may be more potent in adipose tissue due to 
its effects on lipid storage (Nakamura et al., 2014). 
Even though both DS and LS increased depos-
ition of EPA and DHA in subcutaneous adipose 
tissue, it is possible that our dose of 18 mg/kg meta-
bolic BW was too low to activate PPARα there. 
Another factor for the lack of effects on lipolytic 
gene expression could be free fatty acid receptor 4 
(FFAR4). Both EPA and DHA can serve as ligands 
of FFAR4, which is expressed in adipose, and has 
effects on adipogenesis and inflammation (Oh and 
Walenta, 2014). Free fatty acid receptor 4 may have 
a proadipogenic function in adipose tissue, as find-
ings in humans and mice suggest that dysfunction 
of FFAR4 may decrease adipocyte differentiation 
and lipogenesis and enhance hepatic lipogenesis 
in obesity (Ichimura et al., 2012). In addition, the 
knockdown of FFAR4 in 2T3-L1 murine adipo-
cytes inhibited the expression of adipogenic genes 
and impaired lipid accumulation (Gotoh et  al., 
2007). Thus, binding of ligands to FFAR4 may pro-
mote expression of lipogenic genes. Expression of 
FFAR4 in bovine subcutaneous adipose tissue has 
been confirmed by Agrawal et al. (2017). Although 
the expression of FFAR4 was not measured in the 
present study, it is possible that EPA and DHA 
could have been bound by FFAR4 in subcutaneous 
adipose tissue to increase lipogenic gene expression. 
This possible binding may explain the potential for 
increased FA synthesis observed in subcutaneous 
adipose tissue with LS and DS of EPA + DHA 
compared with PFAD.
Adipokine and hormone receptor genes in sub-
cutaneous adipose tissue. In subcutaneous adipose 
tissue, there was a tendency for the expression of 
both adiponectin (P  =  0.07; Table 6) and leptin 
(P  =  0.08) to be lower in lambs supplemented 
with EPA + DHA compared with PFAD. The ex-
pression of resistin in adipose tissue also tended 
(P = 0.07) to be greater with LS of EPA + DHA. 
Leptin is an adipokine that has effects on food in-
take and increasing energy expenditure (Contreras 
et al., 2017), whereas adiponectin improves insulin 
sensitivity and lipogenesis in adipose tissue (Stern 
et  al., 2016). Adiponectin and leptin have been 
shown to have opposite concentrations (Matsubara 
et al., 2002), so it is surprising that there was a ten-
dency for adiponectin and leptin to both decrease 
with LS of EPA + DHA vs. PFAD. Little is known 
about the functions of resistin across species; how-
ever, studies in dairy cattle have found that resistin 
is positively correlated with NEFA concentrations, 
suggesting a role in increasing lipolysis (Reverchon 
et al., 2014; Weber et al., 2016). As presented in a 
companion paper, no differences were observed in 
the plasma concentration of NEFA in our lambs 
(Carranza-Martin et al., 2018). Thus, the tendency 
for higher resistin expression in subcutaneous adi-
pose tissue with LS of EPA + DHA compared 
with PFAD does not fit with our data for plasma 
metabolites. It is possible that the expression of 
genes for adipokines did not translate to changes 
in protein expression. This may explain why the 
mRNA expression of adiponectin and leptin were 
not opposite as expected, and why the expression 
of resistin does not fit with plasma NEFA concen-
trations. However, as mentioned earlier, protein ex-
pression, nor plasma concentrations of adipokines, 
were measured in this study. The lack of differences 
in the mRNA expression of GIP receptor, insulin 
receptor, and ghrelin receptor is not unexpected be-
cause, as mentioned earlier, plasma concentrations 
of metabolites were not different between LS of 
EPA + DHA and PFAD (Carranza-Martin et al., 
2018).
Only one DS effect was observed for the 
adipokine and hormone receptor genes measured 
in subcutaneous adipose tissue; expression of the 
GIP receptor in adipose tissue was lower in lambs 
born from dams supplemented with EPA + DHA 
vs. PFAD during late gestation (P = 0.01). The DS 
effect on mRNA expression of GIP receptor is un-
expected due to the lack of DS effects on plasma 
metabolites in the present study (Carranza-Martin 
et al., 2018). The GIP receptor is expressed in adi-
pocytes, where GIP stimulation increases the uptake 
of nutrients into adipocytes (Yamada and Seino, 
2004). Thus, without differences in plasma metab-
olites, the lambs would not have needed increased 
GIP receptors to take up more nutrients. In add-
ition, there were no differences in the plasma con-
centrations of insulin and ghrelin, or metabolites 
of their dams (Coleman et al., 2018b), or in the ex-
pression of genes for hormone receptors in the sub-
cutaneous adipose tissue of their dams (Coleman 
et  al., 2018a). Without changes in metabolites or 
maternal hormone receptors in adipose tissue, it 
3086 Coleman et al.
is unclear why the expression of GIP receptor was 
different in finishing lamb subcutaneous adipose 
tissue with DS of EPA + DHA compared with 
PFAD. However, Miyawaki et  al. (2002) showed 
that GIP and its receptor are associated with feed 
efficiency, where GIP receptor knockout mice had a 
lower respiratory quotient when fed a high-energy 
diet, indicating that they were using more fat as an 
energy source. We report in the companion paper 
(Carranza-Martin et al., 2018) that lambs with DS 
of EPA + DHA were, on average, heavier during 
the finishing period than lambs with DS of PFAD. 
This difference in BW could be associated with the 
decreased expression of GIP receptor in the sub-
cutaneous adipose tissue, independent of the me-
tabolite or hormone concentrations. More work 
is needed to understand the potential associations 
between maternal supplementation of EPA and 
DHA and offspring performance and GIP receptor 
mRNA expression.
Inflammatory response genes in subcutaneous 
adipose tissue. No differences (P > 0.30; Table 6) 
were observed between DS or LS in the expression 
of COX-2 or 5-LOX in subcutaneous adipose. The 
expression of inflammatory response genes in sub-
cutaneous adipose tissue is different than that of 
liver tissue, where 5-LOX was altered by LS. As nei-
ther tissue was in an inflammatory state, it is not 
known why expression of 5-LOX was altered in 
liver and not subcutaneous adipose tissue. As de-
scribed earlier, EPA and DHA may modulate ex-
pression of 5-LOX via PPAR (Lee et  al., 2010). 
Compared with subcutaneous adipose, changes 
in hepatic expression of genes related to FA syn-
thesis, uptake, and release suggest a greater activa-
tion of PPARα by LS of EPA + DHA vs. PFAD. 
This greater activation in liver tissue may explain 
why 5-LOX expression was altered in liver vs. sub-
cutaneous adipose tissue, even though the level of 
expression was similar between the 2 tissues.
An interaction exists between DS and LS of 
Ca salts enriched with EPA and DHA on lamb 
tissue FA concentrations and mRNA expression. 
However, the response may be tissue dependent 
as more interactions between DS and LS were ob-
served in subcutaneous adipose tissue compared 
with liver tissue. In addition, dam and lamb sup-
plementation with an enriched source of EPA and 
DHA both independently altered liver and subcuta-
neous adipose tissue FA and mRNA expression. 
Importantly, supplementation with EPA and DHA 
during the finishing period increased the concentra-
tions of these FA in both liver and subcutaneous 
adipose tissue. Lamb supplementation of an en-
riched source of EPA and DHA altered hepatic 
FA and mRNA concentrations toward increased 
lipolysis and decreased lipogenesis compared with 
supplementation of a Ca salt of PFAD. Maternal 
supplementation of Ca salts enriched with EPA and 
DHA during late gestation may alter liver tissue in 
the same way; however, changes were less evident. 
Changes in subcutaneous adipose tissue FA suggest 
that maternal and finishing period supplementation 
with EPA and DHA altered lipogenesis. However, 
there were no changes in mRNA expression of lipo-
genic genes with DS or LS of an enriched source of 
EPA and DHA compared with a source of PFAD. 
Thus, more work is needed to understand the mech-
anisms by which supplementing Ca salts enriched 
in EPA and DHA to dams during late gestation and 
their offspring during the finishing period may have 
increased lipogenesis, and the potential fetal pro-
gramming effects of these FA.
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